StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

NovaBridge Biosciences's price to sales ratio was 19.7× on Feb 28, 2025, against 28.1× a year earlier. Over the last 3 years it ranged from 5.8× to 93.5×, with a median of 27.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Feb 28, 202519.7×+1.6
2024Dec 31, 202418.1×−10.0
2023Feb 28, 202328.1×+0.9
2022Dec 30, 202227.2×−6.2
2020Oct 30, 202033.4×–

More NovaBridge Biosciences figures

See a number that looks wrong?